Diabetes
Conference Coverage
Short-term use of CGMs can deliver life-changing data for patients with type 2 diabetes
LOS ANGELES –
Commentary
ERRATUM
News
FDA approves Qternmet XR as adjunct therapy for glycemic improvement in type 2 diabetes
FDA approval is based on results from a pair of phase 3 trials that tested different combinations of dapagliflozin and saxagliptin.
From the Journals
Fournier gangrene cases surge in patients using SGLT2 inhibitors
Serious complications and death are likely if Fournier gangrene is not recognized.
Latest News
Weight-loss drug options expand, but beware cardiac risk
LOS ANGELES – Even diabetes drugs can help patients shed pounds, but more powerful alternatives are available.
Conference Coverage
Liraglutide seems safe, effective in children already on metformin
Liraglutide seems to be safe and effective for children and adolescents with type 2 diabetes who are already on metformin therapy.
Conference Coverage
Type 2 diabetes bumps up short-term risk for bone fracture
Evaluation of risk factors for short- and long-term fracture risk may help improve risk stratification in patients with type 2 diabetes.
Conference Coverage
‘Mammogram of the heart’: Inside coronary artery calcium scores
Cardiac risks varies widely in diabetes, cardiologist says, and CAC tests offer valuable insight
From the Journals
No single eating pattern stands out as best for nutritional therapy in diabetes
A one-size-fits-all prescription would be unrealistic given the diversity of patients and eating patterns, panel says.
Conference Coverage
Intermittent fasting tied to positive physiological effects
PHILADELPHIA - But it may be associated with certain risks.
Video
Dr. Douglas Paauw gives updates on antihypertensives, statins, SGLT2 inhibitors
PHILADELPHIA – This past year has been a tough one for ARBs.